CIK 0001535955 · Non-accelerated filer<br>Smaller reporting company
Lipocine Inc.
Sign in to watch- Ticker
- LPCN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 990370688
- Phone
- 801 994 7383
- Business address
- 675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, United States, 84108
- Former names
- MARATHON BAR CORP
- Open-market buys, last 90 days
- $161,662
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$161,662. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 52 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-20 | Ono Richard Dana Director | Purchase | +4,000 | $0.34 | $1K | 14,125 |
| 2023-03-17 | Patel Mahesh V. CEO and President | Purchase | +50,000 | $0.33 | $17K | 1,528,090 |
| 2023-01-03 | Patel Mahesh V. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | $0.41 | $123K | 2,542,395 |
| 2022-12-22 | Patel Mahesh V. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +112,500 | $0.41 | $46K | 2,242,395 |
| 2022-12-22 | Fogarty Krista Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +91,850 | $0.41 | $38K | 229,850 |
| 2022-11-22 | Papapetropoulos Spyros Director | Purchase | +21,739 | $0.47 | $10K | 21,739 |
| 2022-11-14 | Patel Mahesh V. CEO and President | Purchase | +75,000 | $0.39 | $29K | 1,478,090 |
| 2022-11-01 | Nomikos George Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | $0.41 | $51K | 125,000 |
| 2022-09-27 | Patel Mahesh V. CEO and President | Purchase | +100,000 | $0.41 | $41K | 1,403,090 |
| 2022-06-08 | Ono Richard Dana Director | Grant or award · Common Stock (Right to Buy) | +22,000 | $0.92 | $20K | 136,000 |
| 2022-06-08 | Higuchi John W. Director | Grant or award · Common Stock (Right to Buy) | +22,000 | $0.92 | $20K | 307,490 |
| 2022-06-08 | Papapetropoulos Spyros Director | Grant or award · Stock Option (Right to Buy) | +22,000 | $0.92 | $20K | 32,000 |
| 2022-06-08 | Fink Jeffrey Arvin Director | Grant or award · Common Stock (Right to Buy) | +22,000 | $0.92 | $20K | 136,000 |
| 2022-06-08 | Jene Jill M. Director | Grant or award · Stock Option (Right to Buy) | +22,000 | $0.92 | $20K | 32,000 |
| 2022-05-17 | Fogarty Krista Principal Accounting Officer | Purchase | +12,500 | $0.86 | $11K | 12,500 |
| 2022-05-16 | Patel Mahesh V. CEO and President | Purchase | +50,000 | $0.77 | $38K | 1,303,090 |
| 2022-04-11 | Papapetropoulos Spyros Director | Grant or award · Stock Option (Right to Buy) | +10,000 | $1.16 | $12K | 10,000 |
| 2022-04-11 | Jene Jill M. Director | Grant or award · Stock Option (Right to Buy) | +10,000 | $1.16 | $12K | 10,000 |
| 2022-01-03 | Patel Mahesh V. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +287,500 | $1.09 | $313K | 287,500 |
| 2021-12-07 | Patel Mahesh V. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | $1.12 | $140K | 125,000 |
Page 3 of 8 · 144 trades